EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis

Qazi Mohammad Sajid Jamal, Ali H Alharbi iD, Varish Ahmad, Khurshid Ahmad iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0328457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Qazi Mohammad Sajid Jamal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Informatics, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Salman Center for Disability Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) remains a major neurodegenerative disorder, characterized by cognitive decline alongside functional impairments that affect daily living. Natural therapeutic alternatives have spurred the search for novel inhibitors targeting acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), two well-established targets in AD therapy. This study utilizes an in silico methodology to investigate new cholinesterase inhibitors sourced from Nyctanthes arbor-tristis, a plant known for its abundant bioactive phytochemicals. Through virtual screening, molecular dynamics simulations (MDS), free energy landscape analysis, and ADMET predictions, eight compounds have been identified as potential inhibitors of AChE and/or BChE. These compounds include Apigenin, Arborside-B, Arbortristoside-D, Arbortristoside-E, Nicotiflorin, Arborside-A, Beta-amyrin, and Nyctanthic acid. These compounds exhibited robust binding affinities compared to the control, advantageous ADMET profiles, and sustained stability throughout 200 ns of MDS and energy assessments, highlighting their potential as viable drug candidates for further exploration. Further experimental studies are required to validate their therapeutic efficacies, thereby confirming their potential as neurological therapeutics for the treatment of AD and related disabilities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholinesterase InhibitorsPlant ExtractsButyrylcholinesteraseMolecular Dynamics SimulationHumansAcetylcholinesteraseMolecular Docking SimulationComputer SimulationAlzheimer Disease

Substanzen

Cholinesterase InhibitorsButyrylcholinesteraseAcetylcholinesterasePlant Extracts

Autor:innen und Institutionen

  • Department of Health Informatics, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
  • King Salman Center for Disability Research, Riyadh, Saudi Arabia.
  • Health Information Technology Department, The Applied College, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Ali H Alharbi, Khurshid Ahmad

Förderung

  • King Salman Center for Disability Research

Zitieren

APA

Jamal, Q. M. S., Alharbi, A. H., Ahmad, V., & Ahmad, K. (2025). Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis. PLOS One. https://doi.org/10.1371/journal.pone.0328457

Vancouver

Jamal QMS, Alharbi AH, Ahmad V, Ahmad K. Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis. PLOS One. 2025. doi:10.1371/journal.pone.0328457

BibTeX
@article{Jamal2025,
  author = {Jamal, Qazi Mohammad Sajid and Alharbi, Ali H and Ahmad, Varish and Ahmad, Khurshid},
  title = {Integrated in silico identification of cholinesterase inhibitors from Nyctanthes arbor-tristis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328457}
}
Kostenlos starten →